Precision Prediction & Precision Medicine
Testing for the persistence of glutamic acid decarboxylase antibodies (GADA) is worthwhile irrespective of diabetes duration, as it can help rectify possible misdiagnoses, according to this paper’s authors.
In a letter to The Lancet Diabetes & Endocrinology, the authors respond to a previous comment in the journal calling for an optimization of diagnostic accuracy at the onset of diabetes in children and adolescents. The Diabeter centres frequently see referred people with diabetes who have been potentially misclassified as having type 1 diabetes on the basis of clinical characteristics alone. The letter provides details of a cross-sectional study at Diabeter involving 990 people with diabetes.
Please click here for the pdf file.